5 November 2012

International Consortium Awarded 6 Million Euro To Validate Pre-Eclampsia Early Detection Tests.More

2 November 2012

Genkyotex's NOX Inhibitor GKT137831 Phase I Data Presented at Kidney Week 2012.More

25 October 2012

Thrasos Secures $35 Million to Fund THR-184 Phase 2 Clinical Program for Treatment of Acute Kidney Injury.More

17 October 2012

Covagen enters into a strategic research collaboration and
license agreement with Mitsubishi Tanabe for the development of
bispecific FynomAbs.More

10 October 2012

Genocea Closes $30 Million in Series C Financing. The Bill & Melinda Gates Foundation and CVF join as new investors.More

15 August 2012

Genocea Initiates a Phase 1/2a Study with its Therapeutic Vaccine Candidate for Herpes Simplex Virus-2 (HSV-2)More